LNTH Stock Summary and Trading Ideas (Lantheus Holdings | NASDAQ:LNTH)

Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.

What symbol and exchange does Lantheus Holdings shares trade?

Lantheus Holdings trades on the NASDAQ stock market under the symbol LNTH.

What is Lantheus Holdings stock price doing today?

As of August 7, 2026, LNTH stock price declined to $100.95 with 1,744,054 million shares trading.

What is Lantheus Holdings's Beta?

LNTH has a beta of 0.51, meaning it tends to be less sensitive to market movements. LNTH has a correlation of 0.02 to the broad based SPY ETF.

How much is Lantheus Holdings worth?

LNTH has a market cap of $6.57 billion. This is considered a Mid Cap stock.

How much money does Lantheus Holdings make?

Last quarter Lantheus Holdings reported $388 million in Revenue and $1.55 earnings per share. This beat revenue expectation by $24 million and exceeded earnings estimates by $.29.

What is the highest and lowest price Lantheus Holdings traded in the last 3 year period?

In the last 3 years, LNTH traded as high as $126.89 and as low as $47.25.

What are the top ETFs holding Lantheus Holdings?

The top ETF exchange traded funds that LNTH belongs to (by Net Assets): AVUV, VTI, IJH, IWM, VB.

Is Lantheus Holdings (LNTH) a good investment?

LNTH has outperformed the market in the last year with a return of +94.6%, while the SPY ETF gained +23.4%. In the last 3 month period, LNTH beat the market returning +17.2%, while SPY returned +5.6%. However, in the most recent 2 weeks LNTH has underperformed the stock market by returning -2.7%, while SPY returned +4.8%.

What are the support and resistance levels for Lantheus Holdings (LNTH)?

LNTH support price is $98.35 and resistance is $103.79 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LNTH shares will trade within this expected range on the day.